Zobrazeno 1 - 10
of 72
pro vyhledávání: '"Yoichi Furuya"'
Publikováno v:
npj Vaccines, Vol 6, Iss 1, Pp 1-14 (2021)
Abstract The precise mechanism by which many virus-based vectors activate immune responses remains unknown. Dendritic cells (DCs) play key roles in priming T cell responses and controlling virus replication, but their functions in generating protecti
Externí odkaz:
https://doaj.org/article/9f635bc15de044ad91eccd5d62ec3467
Autor:
Clare M Williams, Sreeja Roy, Wei Sun, Andrea M Furuya, Danushka K Wijesundara, Yoichi Furuya
Publikováno v:
Clinical & Translational Immunology, Vol 11, Iss 3, Pp n/a-n/a (2022)
Abstract Group 2 innate lymphoid cells (ILC2) are a relatively new class of innate immune cells. Lung ILC2 are early responders that secrete type 2 cytokines in response to danger ‘alarmin’ signals such as interleukin (IL)‐33 and thymic stromal
Externí odkaz:
https://doaj.org/article/d2996f0cafee4670aa3b8594262405bc
Publikováno v:
Health Science Reports, Vol 4, Iss 3, Pp n/a-n/a (2021)
Externí odkaz:
https://doaj.org/article/ba3f5840dbed4f09a225a9e984b91072
Publikováno v:
Bio-Protocol, Vol 10, Iss 8 (2020)
Asthma is a global problem that affects millions of individuals. An increased risk of respiratory viral and bacterial infections is one of the complications of asthma. We recently reported that mice with ovalbumin-induced allergic airway disease (AAD
Externí odkaz:
https://doaj.org/article/9f299466806342fda1af9b20cd6f7260
Publikováno v:
Vaccines, Vol 9, Iss 10, p 1198 (2021)
As influenza season was approaching in 2020, public health officials feared that influenza would worsen the COVID-19 situation [...]
Externí odkaz:
https://doaj.org/article/3d96039992134010ae8ac4b6acedf996
Autor:
Sean Roberts, Sharon L. Salmon, Donald J. Steiner, Clare M. Williams, Dennis W. Metzger, Yoichi Furuya
Publikováno v:
mBio, Vol 10, Iss 4 (2019)
ABSTRACT Fatal outcomes following influenza infection are often associated with secondary bacterial infections. Allergic airway disease (AAD) is known to influence severe complications from respiratory infections, and yet the mechanistic effect of AA
Externí odkaz:
https://doaj.org/article/9dd5786ecf724d57874c90af930d89a7
Publikováno v:
Pathogens, Vol 9, Iss 11, p 928 (2020)
Despite accumulating preclinical data demonstrating a crucial role of cytotoxic T cell immunity during viral infections, ongoing efforts on developing COVID-19 vaccines are mostly focused on antibodies. In this commentary article, we discuss potentia
Externí odkaz:
https://doaj.org/article/6d622e712cf64590a14608c1eaac82f5
Publikováno v:
Vaccines, Vol 8, Iss 4, p 683 (2020)
During the previous influenza seasons, between 2010 and 2016, the live attenuated influenza vaccine (LAIV) provided variable efficacy against influenza in the U.S., causing the recommendation against the use of the LAIV. In striking contrast, pre-cli
Externí odkaz:
https://doaj.org/article/f60d06e423bb4ec8beba21c5c81737ad
Autor:
Sean Roberts, Clare M. Williams, Sharon L. Salmon, Jesse L. Bonin, Dennis W. Metzger, Yoichi Furuya
Publikováno v:
Vaccines, Vol 7, Iss 4, p 146 (2019)
Secondary bacterial pneumonia is responsible for significant morbidity and mortality during seasonal and pandemic influenza. Due to the unpredictability of influenza A virus evolution and the time-consuming process of manufacturing strain-specific in
Externí odkaz:
https://doaj.org/article/cc68d25350c148e0acb6948fa6b059b1
Autor:
Yoichi Furuya, Andrea K M Furuya, Sean Roberts, Alan M Sanfilippo, Sharon L Salmon, Dennis W Metzger
Publikováno v:
PLoS Pathogens, Vol 11, Iss 9, p e1005180 (2015)
Asthma is believed to be a risk factor for influenza infection, however little experimental evidence exists to directly demonstrate the impact of asthma on susceptibility to influenza infection. Using a mouse model, we now report that asthmatic mice
Externí odkaz:
https://doaj.org/article/25588618c33c4cba9a685d60dcbf4d46